{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:38:34Z","timestamp":1793367514808,"version":"4.5.0"},"reference-count":71,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>The prevalence of human papillomavirus (HPV) infection varies worldwide. The high-risk viruses are usually associated with cancers of the cervix, vagina, and vulva in women, cancer of the penis in men, and cancers of the anus, tonsils, oropharynx, and base of the tongue in both sexes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives.\u2014<\/jats:title>\n                    <jats:p>To review literature about the challenges and burden associated with HPV infection in low-resource (ie, developing) countries, focusing on sub-Saharan Africa. To review the prevention, incidence, prevalence, morbidity, and mortality of HPV infections in sub-Saharan Africa. To review the therapy and management of HPV infections in low-resource countries in comparison to developed countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources.\u2014<\/jats:title>\n                    <jats:p>Peer-reviewed literature and experience of some of the authors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Sub-Saharan Africa has high HPV infection prevalence rates, with predominance of high-risk subtypes 16, 18, and 45. The difficulty of access to health care has led to higher morbidity and mortality related to HPV-related cancers. Improvement in screening programs will help in monitoring the spread of HPV infections. Survival studies can be more informative if reliable cancer registries are improved. HPV vaccination is not yet widely available and this may be the key to curtailing the spread of HPV infections in resource-poor countries.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2017-0565-ra","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T08:33:59Z","timestamp":1527755639000},"page":"696-699","source":"Crossref","is-referenced-by-count":9,"title":["Challenges of Human Papillomavirus Infection and Associated Diseases in Low-Resource Countries"],"prefix":"10.5858","volume":"142","author":[{"given":"Michael Chukwugoziem","family":"Nweke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement Abu","family":"Okolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Daous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olukemi Ayotunde","family":"Esan","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University College Hospital Ibadan, Ibadan, Nigeria (Messrs Nweke and Okolo); and the Department of Pathology, West Virginia University, Morgantown (Drs Daous and Esan)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"1","key":"2020081217363765300_i1543-2165-142-6-696-b01","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and Proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"issue":"suppl 5","key":"2020081217363765300_i1543-2165-142-6-696-b02","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.vaccine.2012.06.083","article-title":"The biology and life-cycle of human papillomaviruses","volume":"30","author":"Doorbar","year":"2012","journal-title":"Vaccine"},{"issue":"suppl 3","key":"2020081217363765300_i1543-2165-142-6-696-b03","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Mu\u00f1oz","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"2020081217363765300_i1543-2165-142-6-696-b04","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"2020081217363765300_i1543-2165-142-6-696-b05","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-9378-4-8","article-title":"Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline","volume":"4","author":"Schiffman","year":"2009","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"2020081217363765300_i1543-2165-142-6-696-b06","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/CS20050369","article-title":"Molecular biology of human papillomavirus infection and cervical cancer","volume":"110","author":"Doorbar","year":"2006","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"2020081217363765300_i1543-2165-142-6-696-b07","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers: a brief historical account","volume":"384","author":"Zur Hausen","year":"2009","journal-title":"Virology"},{"issue":"12","key":"2020081217363765300_i1543-2165-142-6-696-b08","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"issue":"suppl 4","key":"2020081217363765300_i1543-2165-142-6-696-b09","article-title":"Human papillomavirus (HPV) and related cancers in the global alliance for vaccines and immunization (GAVI) countries: a WHO\/ICO HPV Information Centre Report Preface","volume":"30","author":"Bosch","year":"2012","journal-title":"Vaccine"},{"issue":"18","key":"2020081217363765300_i1543-2165-142-6-696-b10","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1002\/cncr.27410","article-title":"Cancer burden in Africa and opportunities for prevention","volume":"118","author":"Jemal","year":"2012","journal-title":"Cancer"},{"issue":"12","key":"2020081217363765300_i1543-2165-142-6-696-b11","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"issue":"suppl 5","key":"2020081217363765300_i1543-2165-142-6-696-b12","doi-asserted-by":"crossref","first-page":"F32","DOI":"10.1016\/j.vaccine.2012.07.092","article-title":"The burden of human papillomavirus infections and related diseases in sub-saharan Africa","volume":"31","author":"De Vuyst","year":"2013","journal-title":"Vaccine"},{"issue":"suppl 5","key":"2020081217363765300_i1543-2165-142-6-696-b13","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"2020081217363765300_i1543-2165-142-6-696-b14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer"},{"issue":"1","key":"2020081217363765300_i1543-2165-142-6-696-b15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"issue":"10","key":"2020081217363765300_i1543-2165-142-6-696-b16","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"issue":"3","key":"2020081217363765300_i1543-2165-142-6-696-b17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"issue":"1","key":"2020081217363765300_i1543-2165-142-6-696-b18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-9378-5-24","article-title":"Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria","volume":"5","author":"Okolo","year":"2010","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"2020081217363765300_i1543-2165-142-6-696-b19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"issue":"11","key":"2020081217363765300_i1543-2165-142-6-696-b20","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/sj.bjc.6605664","article-title":"Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan","volume":"102","author":"Raza","year":"2010","journal-title":"Br J Cancer"},{"issue":"4","key":"2020081217363765300_i1543-2165-142-6-696-b21","doi-asserted-by":"crossref","first-page":"e0122488","DOI":"10.1371\/journal.pone.0122488","article-title":"Prevalence of human papillomavirus genotypes among african women with normal cervical cytology and neoplasia: a systematic review and meta-analysis","volume":"10","author":"Ogembo","year":"2015","journal-title":"PLoS One"},{"key":"2020081217363765300_i1543-2165-142-6-696-b22","unstructured":"AIDS by the Numbers 2015: UNAIDS. http:\/\/www.unaids.org\/en\/resources\/documents\/2015\/AIDS_by_the_numbers_2015. Published November 24, 2015. Accessed February 8, 2018."},{"issue":"18","key":"2020081217363765300_i1543-2165-142-6-696-b23","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/01.aids.0000253361.63578.14","article-title":"Human papillomavirus types among women infected with HIV: a meta-analysis","volume":"20","author":"Clifford","year":"2006","journal-title":"AIDS"},{"issue":"6","key":"2020081217363765300_i1543-2165-142-6-696-b24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"De Martel","year":"2015","journal-title":"Lancet Oncol"},{"key":"2020081217363765300_i1543-2165-142-6-696-b25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fonc.2016.00216","article-title":"Burden of cancers attributable to infectious agents in Nigeria: 2012\u20132014","volume":"6","author":"Odutola","year":"2016","journal-title":"Front Oncol"},{"issue":"suppl 3","key":"2020081217363765300_i1543-2165-142-6-696-b26","first-page":"S3\/11","article-title":"Chapter 2: the burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"2020081217363765300_i1543-2165-142-6-696-b27","first-page":"232","article-title":"Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among hispanic men","volume":"29","author":"Col\u00f3n-L\u00f3pez","year":"2010","journal-title":"P R Health Sci J"},{"key":"2020081217363765300_i1543-2165-142-6-696-b28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pvr.2015.09.001","article-title":"An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study","volume":"1","author":"Ingles","year":"2015","journal-title":"Papillomavirus Res"},{"issue":"8","key":"2020081217363765300_i1543-2165-142-6-696-b29","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/507432","article-title":"Prevalence of HPV infection among men: a systematic review of the literature","volume":"194","author":"Dunne","year":"2006","journal-title":"J Infect Dis"},{"issue":"5","key":"2020081217363765300_i1543-2165-142-6-696-b30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjc.6600194","article-title":"Prevalence and determinants of human papillomavirus genital infection in men","volume":"86","author":"Franceschi","year":"2002","journal-title":"Br J Cancer"},{"issue":"3","key":"2020081217363765300_i1543-2165-142-6-696-b31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/sti.78.3.215","article-title":"Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic","volume":"78","author":"Svare","year":"2002","journal-title":"Sex Transm Infect"},{"issue":"2","key":"2020081217363765300_i1543-2165-142-6-696-b32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1086\/514052","article-title":"Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia","volume":"176","author":"Castellsagu\u00e9","year":"1997","journal-title":"J Infect Dis"},{"issue":"10","key":"2020081217363765300_i1543-2165-142-6-696-b33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.olq.0000140012.02703.10","article-title":"Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic","volume":"31","author":"Baldwin","year":"2004","journal-title":"Sex Transm Dis"},{"issue":"6","key":"2020081217363765300_i1543-2165-142-6-696-b34","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/ijc.24097","article-title":"Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study","volume":"124","author":"Giuliano","year":"2009","journal-title":"Int J Cancer"},{"issue":"808","key":"2020081217363765300_i1543-2165-142-6-696-b35","first-page":"2883","article-title":"Burden of invasive squamous cell carcinoma of the penis in the United States, 1998\u20132003","volume":"113","author":"Hernandez","year":"2009","journal-title":"Cancer"},{"issue":"3","key":"2020081217363765300_i1543-2165-142-6-696-b36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.molonc.2007.08.005","article-title":"Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7","volume":"1","author":"Lindquist","year":"2007","journal-title":"Mol Oncol"},{"issue":"suppl 5","key":"2020081217363765300_i1543-2165-142-6-696-b37","doi-asserted-by":"crossref","first-page":"F34","DOI":"10.1016\/j.vaccine.2012.05.070","article-title":"Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis","volume":"30","author":"Gillison","year":"2012","journal-title":"Vaccine"},{"issue":"21","key":"2020081217363765300_i1543-2165-142-6-696-b38","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/jnci\/90.21.1626","article-title":"Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection","volume":"90","author":"Schwartz","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"2020081217363765300_i1543-2165-142-6-696-b39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2020081217363765300_i1543-2165-142-6-696-b40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1749-4486.2006.01246.x","article-title":"Human papillomavirus and head and neck cancer: a systematic review and meta-analysis","volume":"31","author":"Hobbs","year":"2006","journal-title":"Clin Otolaryngol"},{"issue":"6","key":"2020081217363765300_i1543-2165-142-6-696-b41","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.oraloncology.2008.07.008","article-title":"Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV","volume":"45","author":"Andrews","year":"2009","journal-title":"Oral Oncol"},{"key":"2020081217363765300_i1543-2165-142-6-696-b42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13027-015-0036-7","article-title":"Impact of human papillomavirus on head and neck squamous cell cancers in Gabon","volume":"10","author":"Labouda","year":"2015","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"2020081217363765300_i1543-2165-142-6-696-b43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7196\/SAMJ.7542","article-title":"Prevalence of oral and oropharyngeal human papillomavirus in a sample of South African men: a pilot study","volume":"104","author":"Davidson","year":"2014","journal-title":"S Afr Med J"},{"issue":"1","key":"2020081217363765300_i1543-2165-142-6-696-b44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1758-3284-1-14","article-title":"Current evidence on the burden of head and neck cancers in Nigeria","volume":"1","author":"Da Lilly-Tariah","year":"2009","journal-title":"Head Neck Oncol"},{"issue":"4","key":"2020081217363765300_i1543-2165-142-6-696-b45","first-page":"280","article-title":"Pattern of head and neck malignant tumours in a Nigerian teaching hospital\u2014a ten year review","volume":"23","author":"Amusa","year":"2004","journal-title":"West Afr J Med"},{"issue":"2","key":"2020081217363765300_i1543-2165-142-6-696-b46","first-page":"111","article-title":"Pattern of head and neck cancers among Nigerians in Lagos","volume":"20","author":"Nwawolo","year":"2001","journal-title":"West Afr J Med"},{"issue":"2","key":"2020081217363765300_i1543-2165-142-6-696-b47","first-page":"77","article-title":"Pattern of head and neck cancer in Sokoto","volume":"3","author":"Iseh","year":"2006","journal-title":"Nig J Otorhinolaryngol"},{"key":"2020081217363765300_i1543-2165-142-6-696-b48","first-page":"117","article-title":"Nasopharyngeal cancer in Nigeria","author":"Okeowo","year":"1978","journal-title":"Ibadan Tropical Medicine Series"},{"issue":"1","key":"2020081217363765300_i1543-2165-142-6-696-b49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1258\/0049475053001949","article-title":"Clinicopathological study of head and neck cancers in Ilorin, Nigeria","volume":"35","author":"Ologe","year":"2005","journal-title":"Trop Doct"},{"issue":"6","key":"2020081217363765300_i1543-2165-142-6-696-b50","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0027-9684(15)31343-2","article-title":"Head and neck cancer\u2014a clinicopathological study in a tertiary care center","volume":"100","author":"Adeyemi","year":"2008","journal-title":"J Natl Med Assoc"},{"issue":"12","key":"2020081217363765300_i1543-2165-142-6-696-b51","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1017\/S0022215100069930","article-title":"Cancer of the naso-pharynx in Nigeria","volume":"82","author":"Martinson","year":"1968","journal-title":"J Laryngol Otol"},{"key":"2020081217363765300_i1543-2165-142-6-696-b52","first-page":"38","article-title":"Primary head and neck malignant tumours in Port Harcourt, Nigeria","volume":"7","author":"Okoye","year":"1995","journal-title":"Orient J Med"},{"issue":"2","key":"2020081217363765300_i1543-2165-142-6-696-b53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4314\/wajm.v23i2.28105","article-title":"Nasopharyngeal cancer at the University College Hospital Ibadan Cancer Registry: an update","volume":"23","author":"Nwaorgu","year":"2004","journal-title":"West Afr J Med"},{"issue":"2","key":"2020081217363765300_i1543-2165-142-6-696-b54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4314\/wajm.v25i2.28256","article-title":"Primary head and neck cancers in Jos, Nigeria: a re-visit","volume":"25","author":"Otoh","year":"2007","journal-title":"West Afr J Med"},{"issue":"11","key":"2020081217363765300_i1543-2165-142-6-696-b55","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1080\/00016480701230936","article-title":"Prevalence of human immunodeficiency virus seropositivity in head and neck malignancies in sub-Saharan Africa","volume":"127","author":"Nwaorgu","year":"2007","journal-title":"Acta Otolaryngol"},{"key":"2020081217363765300_i1543-2165-142-6-696-b56","first-page":"30","article-title":"Otolaryngology in South-Eastern Nigeria III: pattern of diseases of the throat","volume":"13","author":"Okafor","year":"1983","journal-title":"Nig Med J"},{"issue":"2","key":"2020081217363765300_i1543-2165-142-6-696-b57","first-page":"40","article-title":"Cancer of the larynx in black Africans in Jos Nigeria","volume":"45","author":"Da Lilly-Tariah","year":"1999","journal-title":"Cent Afr J Med"},{"issue":"328","key":"2020081217363765300_i1543-2165-142-6-696-b58","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM199301213280306","article-title":"Head and neck cancer","volume":"3","author":"Vokes","year":"1993","journal-title":"N Engl J Med"},{"key":"2020081217363765300_i1543-2165-142-6-696-b59","first-page":"52","article-title":"Cancers of the ear, nose and throat","volume":"10","author":"Da Lilly-Tariah","year":"2000","journal-title":"Nig J Surg Sci"},{"issue":"1","key":"2020081217363765300_i1543-2165-142-6-696-b60","first-page":"45","article-title":"Malignant neoplasms of the ear, nose and throat in north eastern Nigeria","volume":"2","author":"Ahmad","year":"2005","journal-title":"Highl Med Res J"},{"issue":"1","key":"2020081217363765300_i1543-2165-142-6-696-b61","first-page":"69","article-title":"Perception and utilization of cervical cancer screening services among female nurses in University College Hospital, Ibadan, Nigeria","volume":"11","author":"Arulogun","year":"2012","journal-title":"Pan Afr Med J"},{"issue":"3","key":"2020081217363765300_i1543-2165-142-6-696-b62","doi-asserted-by":"crossref","DOI":"10.4172\/2325-9795.1000149","article-title":"Willingness to utilize cervical cancer screening services among, antenatal clinic attendees in selected hospitals in Ibadan, Nigeria","volume":"3","author":"Ndikom","year":"2014","journal-title":"J Womens Health Issues Care"},{"issue":"3","key":"2020081217363765300_i1543-2165-142-6-696-b63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2307\/3583394","article-title":"Awareness of cervical cancer, Papanicolaou's smear and its utilisation among female undergraduates in Ibadan","volume":"8","author":"Ayinde","year":"2004","journal-title":"Afr J Reprod Health"},{"issue":"suppl 5","key":"2020081217363765300_i1543-2165-142-6-696-b64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.vaccine.2012.06.031","article-title":"Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries","volume":"30","author":"Steben","year":"2012","journal-title":"Vaccine"},{"issue":"suppl 5","key":"2020081217363765300_i1543-2165-142-6-696-b65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.vaccine.2012.05.039","article-title":"Human papillomavirus vaccine introduction: the first five years","volume":"30","author":"Markowitz","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"2020081217363765300_i1543-2165-142-6-696-b66","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1470-2045(12)70482-5","article-title":"Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer","volume":"14","author":"Morhason-Bello","year":"2013","journal-title":"Lancet Oncol"},{"key":"2020081217363765300_i1543-2165-142-6-696-b67","first-page":"150","article-title":"Knowledge of the human papilloma virus vaccines, and opinions of gynaecologists on its implementation in Nigeria","volume":"17","author":"Morhason-Bello","year":"2013","journal-title":"Afr J Reprod Health"},{"key":"2020081217363765300_i1543-2165-142-6-696-b68","unstructured":"GAVI Alliance. GAVI Alliance Policy Country Eligibility. 2009:1-4."},{"key":"2020081217363765300_i1543-2165-142-6-696-b69","article-title":"HPV vaccines: not only unproven to protect against cervical cancer but dangerous & unnecessary","author":"Kalell"},{"issue":"suppl 5","key":"2020081217363765300_i1543-2165-142-6-696-b70","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.vaccine.2012.06.075","article-title":"Implementation of human papillomavirus immunization in the developing world","volume":"30","author":"Kane","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"2020081217363765300_i1543-2165-142-6-696-b71","doi-asserted-by":"crossref","first-page":"e90912","DOI":"10.1371\/journal.pone.0090912","article-title":"Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review","volume":"9","author":"Perlman","year":"2014","journal-title":"PLoS One"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/142\/6\/696\/1447443\/arpa_2017-0565-ra.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/142\/6\/696\/1447443\/arpa_2017-0565-ra.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:34:06Z","timestamp":1764790446000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/142\/6\/article-p696.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2017-0565-ra","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}